Sarah Sbita, MD
Family Medicine · Pickerington, OHNPI 1972891844
Payments from drug & device makers
Across 243 payments — averaging $13.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$742
- AstraZeneca$443
- AbbVie$302
- Pfizer$211
- GSK$199
- Lilly USA, LLC$192
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,374100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 63 | $742 |
| AstraZeneca | 29 | $443 |
| AbbVie(2 entities) | 20 | $302 |
| Pfizer | 18 | $211 |
| GSK | 16 | $199 |
| Lilly USA, LLC | 13 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $189 |
| Astellas Pharma US Inc | 7 | $137 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Merck | 6 | $77 |
| Amarin Pharma, Inc. | 4 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Sanofi-aventis U.S. LLC | 5 | $61 |
| Johnson & Johnson | 3 | $47 |
| Corcept Therapeutics | 2 | $46 |
| Amgen(2 entities) | 3 | $45 |
| Exact Sciences | 2 | $39 |
| Neos Therapeutics, LP | 2 | $38 |
| Novartis | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Bayer | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Boehringer Ingelheim | 2 | $26 |
| Gilead | 2 | $26 |
| Sanofi Pasteur Inc. | 2 | $26 |
| Dexcom, Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Abbott | 1 | $19 |
| Vivus LLC | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$3,374 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 84 | $103,641 |
| OzempicSemaglutide | 39 | $66,719 |
| JardianceEmpagliflozin | 31 | $50,151 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $23,958 |
| RybelsusSemaglutide | 20 | $22,190 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $11,726 |
| SymbicortBudesonide/Formoterol Fumarate | 27 | $10,763 |
| Spiriva RespimatTiotropium Bromide | 15 | $7,944 |
| Atorvastatin Calcium | 479 | $7,426 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 21 | $4,372 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 14 | $4,125 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 109 | $3,152 |
| Duloxetine Hcl | 42 | $2,953 |
| Metoprolol Succinate | 144 | $2,418 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 73 | $2,060 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $211 | $103,64184 claims |
| Novo NordiskOzempic, Rybelsus | $742 | $88,90959 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $26 | $58,09546 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $443 | $34,72149 claims |
| GSKTrelegy Ellipta, Shingrix, Arexvy | $199 | $20,22246 claims |
| AbbVieSynthroid | $302 | $83436 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Pickerington
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.